• Issue

    Arthritis & Rheumatism: Volume 63, Issue 2

    311-572
    February 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

In This Issue

In This Issue

  • First Published: 28 January 2011

ACR Presidential Address

Why the ACR?†

Stanley B. Cohen, 
  • Pages: 311-313
  • First Published: 15 December 2010

Review Article

The emerging role of interleukin-1β in autoinflammatory diseases

Helen J. Lachmann,  Pierre Quartier,  Alexander So,  Philip N. Hawkins, 
  • Pages: 314-324
  • First Published: 21 October 2010

Commentary

Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?

Steven L. Teitelbaum,  Margaret P. Seton,  Kenneth G. Saag, 
  • Pages: 325-328
  • First Published: 08 November 2010

Editorial

Syk kinase inhibitors for rheumatoid arthritis: Trials and tribulations

Maarten Boers, 
  • Pages: 329-330
  • First Published: 27 October 2010

Histidyl–transfer RNA synthetase: A key participant in idiopathic inflammatory myopathies

Livia Casciola-Rosen, 
  • Pages: 331-333
  • First Published: 27 October 2010

How does interferon-α insult the vasculature? Let me count the ways

Mariana J. Kaplan,  Jane E. Salmon, 
  • Pages: 334-336
  • First Published: 29 November 2010

Rheumatoid Arthritis

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents†

Mark C. Genovese,  Arthur Kavanaugh,  Michael E. Weinblatt,  Charles Peterfy,  Julie DiCarlo,  Michael L. White,  Maryann O'Brien,  Elliott B. Grossbard,  Daniel B. Magilavy, 
  • Pages: 337-345
  • First Published: 27 October 2010

The incidence of gastrointestinal perforations among rheumatoid arthritis patients

Jeffrey R. Curtis,  Fenglong Xie,  Lang Chen,  Claire Spettell,  Raechele M. McMahan,  Joaquim Fernandes,  Elizabeth Delzell, 
  • Pages: 346-351
  • First Published: 21 October 2010

The risk of cancer in patients with rheumatoid arthritis: A nationwide cohort study in Taiwan†

Yi-Ju Chen,  Yun-Ting Chang,  Chang-Bi Wang,  Chun-Ying Wu, 
  • Pages: 352-358
  • First Published: 04 November 2010

Body mass index and clinical response to infliximab in rheumatoid arthritis†‡

Ruth Klaasen,  Carla A. Wijbrandts,  Danielle M. Gerlag,  Paul P. Tak, 
  • Pages: 359-364
  • First Published: 08 November 2010

The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case–control samples

Luis Rodríguez-Rodríguez,  Wan Rohani Wan Taib,  Ruth Topless,  Sophia Steer,  María F. González-Escribano,  Alejandro Balsa,  Dora Pascual-Salcedo,  Miguel A. González-Gay,  Enrique Raya,  Benjamín Fernandez-Gutierrez,  Isidoro González-Álvaro,  Nunzio Bottini,  Torsten Witte,  Marte K. Viken,  Marieke J. H. Coenen,  Piet L. C. M. van Riel,  Barbara Franke,  Martin den Heijer,  Timothy R. D. J. Radstake,  Paul Wordsworth,  Benedicte A. Lie,  Tony R. Merriman,  Javier Martín, 
  • Pages: 365-372
  • First Published: 15 November 2010

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation

Joanna Stanczyk,  Caroline Ospelt,  Emmanuel Karouzakis,  Andrew Filer,  Karim Raza,  Christoph Kolling,  Renate Gay,  Christopher D. Buckley,  Paul P. Tak,  Steffen Gay,  Diego Kyburz, 
  • Pages: 373-381
  • First Published: 27 October 2010

Psoriatic Arthritis

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

Bente Glintborg,  Mikkel Østergaard,  Lene Dreyer,  Niels Steen Krogh,  Ulrik Tarp,  Michael Sejer Hansen,  Signe Rifbjerg-Madsen,  Tove Lorenzen,  Merete Lund Hetland, 
  • Pages: 382-390
  • First Published: 27 October 2010

Osteoarthritis

Synovial inflammation in patients undergoing arthroscopic meniscectomy: Molecular characterization and relationship to symptoms†

Carla R. Scanzello,  Brian McKeon,  Bryan H. Swaim,  Edward DiCarlo,  Eva U. Asomugha,  Veero Kanda,  Anjali Nair,  David M. Lee,  John C. Richmond,  Jeffrey N. Katz,  Mary K. Crow,  Steven R. Goldring, 
  • Pages: 391-400
  • First Published: 08 November 2010

Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage

Ann K. Rosenthal,  Claudia M. Gohr,  James Ninomiya,  Bassam T. Wakim, 
  • Pages: 401-411
  • First Published: 27 October 2010

Clinical Images

Clinical images: Voluminous ectopic tumoral calcinosis of the spine in systemic sclerosis

Cécile Durant MD,  Dominique Farge-Bancel MD, PhD, 
  • Page: 411
  • First Published: 01 October 2010

Crystalline Disease

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment†

Lisa K. Stamp,  John L. O'Donnell,  Mei Zhang,  Jill James,  Christopher Frampton,  Murray L. Barclay,  Peter T. Chapman, 
  • Pages: 412-421
  • First Published: 27 October 2010

Octacalcium phosphate crystals induce inflammation in vivo through interleukin-1 but independent of the NLRP3 inflammasome in mice

Sharmal Narayan,  Borbola Pazar,  Hang-Korng Ea,  Laeticia Kolly,  Nathaliane Bagnoud,  Véronique Chobaz,  Frédéric Lioté,  Thomas Vogl,  Dirk Holzinger,  Alexander Kai-Lik So,  Nathalie Busso, 
  • Pages: 422-433
  • First Published: 15 November 2010

Experimental Arthritis

Infection with an intestinal helminth parasite reduces Freund's complete adjuvant–induced monoarthritis in mice

Meiqing Shi,  Arthur Wang,  David Prescott,  Christopher C. M. Waterhouse,  Shuren Zhang,  Jason J. McDougall,  Keith A. Sharkey,  Derek M. McKay, 
  • Pages: 434-444
  • First Published: 21 October 2010

Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis

Huamei Forsman,  Ulrika Islander,  Emil Andréasson,  Annica Andersson,  Karin Önnheim,  Alexandra Karlström,  Karin Sävman,  Mattias Magnusson,  Kelly L. Brown,  Anna Karlsson, 
  • Pages: 445-454
  • First Published: 27 October 2010

Therapeutic potential of anti–interleukin-17A aptamer: Suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models

Akira Ishiguro,  Taishin Akiyama,  Hironori Adachi,  Jun-Ichiro Inoue,  Yoshikazu Nakamura, 
  • Pages: 455-466
  • First Published: 21 October 2010

Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice

Naotake Tsuboi,  Thomas Ernandez,  Xun Li,  Hiroshi Nishi,  Xavier Cullere,  Divya Mekala,  Melissa Hazen,  Jörg Köhl,  David M. Lee,  Tanya N. Mayadas, 
  • Pages: 467-478
  • First Published: 12 November 2010

Clinical Images

Clinical images: Recurrent effusion of the knee in a “double-layered” discoid lateral meniscus

Angel Checa MD, 
  • Page: 478
  • First Published: 16 September 2010

Myositis

Role of innate immunity in a murine model of histidyl–transfer RNA synthetase (Jo-1)–mediated myositis†

Makoto Soejima,  Eun Ha Kang,  Xinyan Gu,  Yasuhiro Katsumata,  Paula R. Clemens,  Dana P. Ascherman, 
  • Pages: 479-487
  • First Published: 27 October 2010

Disease exacerbation by etanercept in a mouse model of alphaviral arthritis and myositis

Ali Zaid,  Nestor E. Rulli,  Michael S. Rolph,  Andreas Suhrbier,  Suresh Mahalingam, 
  • Pages: 488-491
  • First Published: 27 October 2010

Systemic Lupus Erythematosus

Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: A novel link between interferon-α and atherosclerosis in lupus

Jia Li,  Qiong Fu,  Huijuan Cui,  Bo Qu,  Wen Pan,  Nan Shen,  Chunde Bao, 
  • Pages: 492-502
  • First Published: 29 November 2010

Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production

Ionita C. Ghiran,  Mark L. Zeidel,  Sergey S. Shevkoplyas,  Jennie M. Burns,  George C. Tsokos,  Vasileios C. Kyttaris, 
  • Pages: 503-512
  • First Published: 15 November 2010

Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development

Anders Aune Tveita,  Ole Petter Rekvig, 
  • Pages: 513-522
  • First Published: 04 November 2010

Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV

Kunihiro Ichinose,  Yuang-Taung Juang,  José C. Crispín,  Katalin Kis-Toth,  George C. Tsokos, 
  • Pages: 523-529
  • First Published: 15 October 2010

Systemic Sclerosis

HLA–DRB1*0407 and *1304 are risk factors for scleroderma renal crisis

Binh Nguyen,  Maureen D. Mayes,  Frank C. Arnett,  Deborah del Junco,  John D. Reveille,  Emilio B. Gonzalez,  Hilda T. Draeger,  Marilyn Perry,  Amir Hendiani,  Kiran K. Anand,  Shervin Assassi, 
  • Pages: 530-534
  • First Published: 27 October 2010

Sjögren's Syndrome

MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome†

Ilias Alevizos,  Stefanie Alexander,  R. James Turner,  Gabor G. Illei, 
  • Pages: 535-544
  • First Published: 28 January 2011

Pediatric Rheumatology

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series

Peter A. Nigrovic,  Melissa Mannion,  Femke H. M. Prince,  Andrew Zeft,  C. Egla Rabinovich,  Marion A. J. van Rossum,  Elisabetta Cortis,  Manuela Pardeo,  Paivi M. Miettunen,  Ginger Janow,  James Birmingham,  Aaron Eggebeen,  Erin Janssen,  Andrew I. Shulman,  Mary Beth Son,  Sandy Hong,  Karla Jones,  Norman T. Ilowite,  Randy Q. Cron,  Gloria C. Higgins, 
  • Pages: 545-555
  • First Published: 04 November 2010

DEK in the synovium of patients with juvenile idiopathic arthritis: Characterization of DEK antibodies and posttranslational modification of the DEK autoantigen

Nirit Mor-Vaknin,  Ferdinand Kappes,  Amalie E. Dick,  Maureen Legendre,  Catalina Damoc,  Seagal Teitz-Tennenbaum,  Roland Kwok,  Elisa Ferrando-May,  Barbara S. Adams,  David M. Markovitz, 
  • Pages: 556-567
  • First Published: 08 November 2010

Letter to the Editor

Osteopontin receptor–dependent regulation of Th1 and Th17 responses in autoimmune diseases: Comment on the article by Chen et al

Rui-Xue Leng MD,  Hai-Feng Pan MD,  Dong-Qing Ye MD, PhD, 
  • Page: 568
  • First Published: 04 November 2010

Reply

Reply

Guangjie Chen MD, PhD,  Xin Zhang MSc,  Jingwu Z. Zhang MD, PhD, 
  • Pages: 568-569
  • First Published: 04 November 2010

Letter to the Editor

Premature arthritis is a distinct type II collagen phenotype: Comment on the article by Kannu et al

Kayi Li BHSc,  Carter Thorne MD, FRCPC, FACP, 
  • Page: 569
  • First Published: 15 October 2010

Reply

Reply

Peter Kannu MB ChB, DCH, FRACP,  John F. Bateman BSc Hon, PhD,  Ravi Savarirayan MBBS, MD, FRACP, HGSA, ARCPA, 
  • Pages: 569-570
  • First Published: 15 October 2010

Letter to the Editor

A perspective from India on the 2010 rheumatoid arthritis classification criteria: Comment on the article by Aletaha et al

Arvind Chopra MD, DNB, 
  • Page: 570
  • First Published: 30 November 2010

Reply

Reply

Gillian Hawker MD, MSc, FRCPC,  Alan Silman FRCP, FmedSci, DSc (Hons),  Daniel Aletaha MD, MSc,  Tuhina Neogi MD, PhD, FRCPC, 
  • Pages: 570-571
  • First Published: 30 November 2010

Letter to the Editor

Anti–interleukin-17 therapy for degenerated and herniated human intervertebral disc tissues? Comment on the article by Shamji et al

Haili Wang MD,  Marcus Schiltenwolf MD, PhD, 
  • Pages: 571-572
  • First Published: 12 November 2010

Clinical Image

Clinical Images: Systemic sclerosis–related telangiectases

Andrea Murray MPhys, PhD,  Tonia Moore BSc,  Ariane Herrick MD, FRCP, 
  • Page: 572
  • First Published: 15 October 2010

ACR Announcements

ACR announcements

  • First Published: 28 January 2011